Data to be announced in a premarket press release followed by a conference call at 8:30 am ET CAMBRIDGE, Mass., Dec. 4, 2023 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NRSN) (Nasdaq: NRSN) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results